Literature DB >> 30378268

Association of Alzheimer's genetic loci with mild behavioral impairment.

Shea J Andrews1,2, Zahinoor Ismail3,4,5, Kaarin J Anstey6,7,2, Moyra Mortby6,7.   

Abstract

Mild behavioral impairment (MBI) describes the emergence of later-life neuropsychiatric symptoms (NPS) as an at-risk state for incident cognitive decline and dementia, and for some as a potential manifestation of prodromal dementia. How NPS mechanistically link to the development of mild cognitive impairment and Alzheimer's disease (AD) is not fully understood, with potential mechanisms including shared risk factors related to both NPS and cognitive impairment, or AD pathology promoting NPS. This is the first exploratory study to examine whether AD genetic loci as a genetic risk score (GRS), or individually, are a shared risk factor with MBI. Participants were 1,226 older adults (aged 72-79; 738 males; 763 normal cognition) from the Personality and Total Health Through Life project. MBI was approximated in accordance with Criterion 1 of the ISTAART-AA diagnostic criteria using a transformation algorithm for the neuropsychiatric inventory. A GRS was constructed from 25 AD risk loci. Binomial logistic regression adjusting for age, gender, and education examined the association between GRS and MBI. A higher GRS and APOE*ε4 were associated with increased likelihood of affective dysregulation. Nominally significant associations were observed between MS4A4A-rs4938933*C and MS4A6A-rs610932*G with a reduced likelihood of affective dysregulation; ZCWPW1-rs1476679*C with a reduced likelihood of social inappropriateness and abnormal perception/thought content; BIN1-rs744373*G and EPHA1-rs11767557*C with higher likelihood of abnormal perception/thought content; NME8-rs2718058*G with a reduced likelihood of decreased motivation. These preliminary findings suggest a common genetic etiology between MBI and traditionally recognized cognitive problems observed in AD and improve our understanding of the pathophysiological features underlying MBI.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Alzheimer's disease; MBI; genetic risk score

Mesh:

Substances:

Year:  2018        PMID: 30378268     DOI: 10.1002/ajmg.b.32684

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  17 in total

Review 1.  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

Authors:  Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2022-01-04       Impact factor: 44.711

2.  CCCDTD5 recommendations on early non cognitive markers of dementia: A Canadian consensus.

Authors:  Manuel Montero-Odasso; Frederico Pieruccini-Faria; Zahinoor Ismail; Karen Li; Andrew Lim; Natalie Phillips; Nellie Kamkar; Yanina Sarquis-Adamson; Mark Speechley; Olga Theou; Joe Verghese; Lindsay Wallace; Richard Camicioli
Journal:  Alzheimers Dement (N Y)       Date:  2020-10-17

3.  Neural correlates of the impulse dyscontrol domain of mild behavioral impairment.

Authors:  Sascha Gill; Meng Wang; Pauline Mouches; Deepthi Rajashekar; Tolulope Sajobi; Frank P MacMaster; Eric E Smith; Nils D Forkert; Zahinoor Ismail
Journal:  Int J Geriatr Psychiatry       Date:  2021-04-09       Impact factor: 3.850

4.  Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study.

Authors:  Myuri Ruthirakuhan; Zahinoor Ismail; Nathan Herrmann; Damien Gallagher; Krista L Lanctôt
Journal:  Alzheimers Dement       Date:  2022-02-01       Impact factor: 16.655

5.  Response to Schneider and Goldberg "Composite cognitive and functional measures for early stage Alzheimer's disease trials".

Authors:  Mary Sano; Carolyn W Zhu
Journal:  Alzheimers Dement (Amst)       Date:  2020-05-15

Review 6.  The Dichotomy of Alzheimer's Disease Pathology: Amyloid-β and Tau.

Authors:  J Wesson Ashford
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Prevalence of Mild Behavioral Impairment and Risk of Dementia in a Psychiatric Outpatient Clinic.

Authors:  Teruyuki Matsuoka; Zahinoor Ismail; Jin Narumoto
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

8.  Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals.

Authors:  Firoza Z Lussier; Tharick A Pascoal; Mira Chamoun; Joseph Therriault; Cécile Tissot; Mélissa Savard; Min Su Kang; Sulantha Mathotaarachchi; Andrea L Benedet; Marlee Parsons; Muhammad Naveed Iqbal Qureshi; Émilie M Thomas; Monica Shin; Laurie-Anne Dion; Gassan Massarweh; Jean-Paul Soucy; I-Huang Tsai; Paolo Vitali; Zahinoor Ismail; Pedro Rosa-Neto; Serge Gauthier
Journal:  Alzheimers Dement       Date:  2020-01       Impact factor: 21.566

9.  Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment.

Authors:  James P Naude; Sascha Gill; Sophie Hu; Alexander McGirr; Nils D Forkert; Oury Monchi; Peter K Stys; Eric E Smith; Zahinoor Ismail
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

10.  Mild behavioral impairment is related to frailty in non-dementia older adults: a cross-sectional study.

Authors:  Shaoyi Fan; Ximin Liang; Tianchan Yun; Zhong Pei; Bin Hu; Zahinoor Ismail; Zhimin Yang; Fuping Xu
Journal:  BMC Geriatr       Date:  2020-11-27       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.